Clinical Trials Directory

Trials / Conditions / Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter

Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter

13 registered clinical trials studyying Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter.

StatusTrialSponsorPhase
CompletedFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointe
NCT01846520
City of Hope Medical CenterN/A
TerminatedVeliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Ur
NCT01282333
National Cancer Institute (NCI)Phase 1
CompletedGemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Functi
NCT00478361
M.D. Anderson Cancer CenterPhase 2
CompletedVEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium
NCT00407485
National Cancer Institute (NCI)Phase 2
TerminatedVorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium
NCT00363883
National Cancer Institute (NCI)Phase 2
TerminatedSorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium
NCT00112905
National Cancer Institute (NCI)Phase 2
CompletedSorafenib in Treating Patients With Advanced or Metastatic Cancer of the Urinary Tract
NCT00112671
National Cancer Institute (NCI)Phase 2
CompletedPhase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transition
NCT00072150
National Cancer Institute (NCI)Phase 2
TerminatedTrastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the Urothe
NCT00004856
National Cancer Institute (NCI)Phase 2
CompletedGefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cance
NCT00041106
National Cancer Institute (NCI)Phase 2
CompletedIxabepilone in Treating Patients With Advanced Urinary Tract Cancer
NCT00021099
National Cancer Institute (NCI)Phase 2
CompletedTrastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tra
NCT00005831
National Cancer Institute (NCI)Phase 2
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1